Dr. Abigail L Luken, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 N Fort Thomas Ave Ste 302, Fort Thomas, KY 41075 Phone: 859-441-0139 |
Lisa Raziano, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 85 N Grand Ave, Fort Thomas, KY 41075 Phone: 859-572-3120 |
Sharon Froehle Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 654 Highland Ave Ste 17, Fort Thomas, KY 41075 Phone: 859-441-0139 |
Caitlin Beck Lipscomb, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 654 Highland Ave Ste 17, Fort Thomas, KY 41075 Phone: 859-802-9317 |
Julianna Hollister Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 Carmel Manor Dr, Fort Thomas, KY 41075 Phone: 859-781-5111 |
Amy Jean Martin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 48 Gregory Ln, Fort Thomas, KY 41075 Phone: 859-781-5964 Fax: 859-781-0448 |
Melissa Mcdonald Physical Therapist Medicare: Medicare Enrolled Practice Location: 775 Alexandria Pike, Fort Thomas, KY 41075 Phone: 859-572-1689 Fax: 859-441-0153 |
Mrs. Katherine Leigh Graham, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 100 Carmel Manor Dr, Fort Thomas, KY 41075 Phone: 859-781-5111 |
News Archive
Vaccines have reduced the global burden of disease by preventing an estimated 2 to 3 million deaths worldwide each year. In India, the reduction in annual under-five deaths, from 3.4 to 1.2 million between 1990 and 2015, was largely due to expansions in coverage of routine childhood vaccination.
Pharmacyclics, Inc. today announced the launch of informCLL, a large, observational, prospective registry that will explore the natural history of chronic lymphocytic leukemia (CLL), examine how IMBRUVICA (ibrutinib) and other approved targeted therapies are being used to treat patients with CLL, and provide a comparison to treatments using conventional chemoimmunotherapy (CIT).
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced updates to three clinical development programs.
In a recent survey of palliative care medicine practitioners, nearly three quarters of the sample reported having been "humorously" accused of promoting death; for example, being called "Dr. Death." Most of the remarks came from fellow physicians and other health care professionals. At the same time, the survey found that a third of investigations into accusations of murder or euthanasia against physicians are instigated by fellow members of the health care team.
› Verified 5 days ago